i

iVexSol

30 employees

IVexSol is a lentiviral vector production platform that supplies a consistent source of vectors for successful gene therapy programs.

Basic info

Industry

biotechnology research

Sectors

Manufacturing

Date founded

2019

Funding rounds raised

Total raised

$24M

from 9 investors over 9 rounds

i

iVexSol raised $24M on January 26, 2023

Investors: Casdin Capital, LLC, BioLife Solutions, Bristol-Myers Squibb, UK and Asahi KASEI Medical Europe GmbH

i

iVexSol raised $13M on December 1, 2020

Investors: Casdin Capital, LLC and BioLife Solutions

i

iVexSol raised $250K on August 25, 2020

Investors: Massachusetts Life Sciences Center

i

iVexSol raised $2M on September 26, 2019

Investors: BioLife Solutions and Casdin Capital, LLC

FAQ